Geron (GERN) Stock Forecast & Price Target

Compare

2,438 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

GERN Analyst Ratings

Moderate Buy

5 Buy

2 Hold

1 Sell

Based on 8 analysts giving stock ratings to

Geron

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

GERN Stock 12 Month Forecast

Average Price Target

$3.58

▲(177.52%Upside)

Based on 8 Wall Street analysts offering 12 month price targets for Geron in the last 3 months. The average price target is $3.58 with a high forecast of $6.00 and a low forecast of $1.00. The average price target represents a 177.52% change from the last price of $1.29.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","7":"$7","1.75":"$1.75","3.5":"$3.5","5.25":"$5.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$6.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.58,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$3.58</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$1.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,1.75,3.5,5.25,7],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.38,1.7353846153846153,2.0907692307692307,2.4461538461538463,2.8015384615384615,3.1569230769230767,3.5123076923076924,3.867692307692308,4.223076923076923,4.578461538461538,4.933846153846154,5.28923076923077,5.644615384615385,{"y":6,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.38,1.5492307692307692,1.7184615384615385,1.8876923076923076,2.056923076923077,2.226153846153846,2.3953846153846152,2.5646153846153847,2.733846153846154,2.903076923076923,3.0723076923076924,3.2415384615384615,3.4107692307692306,{"y":3.58,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.38,1.3507692307692307,1.3215384615384616,1.2923076923076922,1.263076923076923,1.2338461538461538,1.2046153846153846,1.1753846153846153,1.146153846153846,1.116923076923077,1.0876923076923077,1.0584615384615383,1.0292307692307692,{"y":1,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":4.34,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.78,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.75,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.41,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.11,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.04,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.54,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.87,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.76,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.48,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.43,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.43,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.38,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$6.00

Average Price Target$3.58

Lowest Price Target$1.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$1.5

Hold

16.28%

Upside

Reiterated

07/12/25

Geron's overall stock score reflects significant financial and operational challenges, with ongoing net losses, negative cash flows, and valuation risks being primary concerns. While there are growth opportunities in expanding product reach and strategic investments, execution risks and the need for profitability improvements weigh heavily on the score. Technical indicators further depict a bearish sentiment, aligning with the financial challenges.

Corinne JohnsonGoldman Sachs

Goldman Sachs

Sell

-22.48%

Downside

Initiated

07/10/25

Geron Corp's Rytelo Faces Market Challenges and Declining Physician Adoption, Supporting Sell Rating

Faisal KhurshidLeerink Partners

Leerink Partners

―

Buy

―

Reiterated

06/01/25

Analysts Offer Insights on Healthcare Companies: Sanofi (NASDAQ: SNY), NovoCure (NASDAQ: NVCR) and Geron (NASDAQ: GERN)

Tara BancroftTD Cowen

TD Cowen

Buy

210.08%

Upside

Reiterated

05/12/25

TD Cowen Sticks to Their Buy Rating for Geron (GERN)

Greg HarrisonScotiabank

Scotiabank

$4→$1.5

Hold

16.28%

Upside

Downgraded

05/08/25

Geron downgraded to Sector Perform from Outperform at ScotiabankGeron downgraded to Sector Perform from Outperform at Scotiabank

Robert DriscollWedbush

Wedbush

$7→$6

Buy

365.12%

Upside

Reiterated

05/08/25

Geron (GERN) Gets a Buy from Wedbush

Peter LawsonBarclays

Barclays

Buy

210.08%

Upside

Reiterated

05/08/25

Barclays Reaffirms Their Buy Rating on Geron (GERN)

Emily BodnarH.C. Wainwright

H.C. Wainwright

―

Hold

―

Reiterated

05/07/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Geron (NASDAQ: GERN) and Immunocore Holdings (NASDAQ: IMCR)

Gil BlumNeedham

Needham

Buy

287.60%

Upside

Reiterated

05/07/25

Positive Growth Prospects for Geron Amid Strategic Expansion and Strong Financial Position

Stephen WilleyStifel Nicolaus

Stifel Nicolaus

Buy

210.08%

Upside

Reiterated

03/12/25

Stifel Nicolaus Sticks to Its Buy Rating for Geron (GERN)

Kalpit PatelB.Riley Financial

B.Riley Financial

$3.5→$2

Hold

55.04%

Upside

Downgraded

02/26/25

Geron downgraded to Neutral from Buy at B. RileyGeron downgraded to Neutral from Buy at B. Riley

Carter GouldCantor Fitzgerald

Cantor Fitzgerald

Buy

597.67%

Upside

Assigned

11/08/24

Barclays Sticks to Its Buy Rating for Geron (GERN)

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$1.5

Hold

16.28%

Upside

Reiterated

07/12/25

Corinne JohnsonGoldman Sachs

Goldman Sachs

Sell

-22.48%

Downside

Initiated

07/10/25

Geron Corp's Rytelo Faces Market Challenges and Declining Physician Adoption, Supporting Sell Rating

Faisal KhurshidLeerink Partners

Leerink Partners

―

Buy

―

Reiterated

06/01/25

Analysts Offer Insights on Healthcare Companies: Sanofi (NASDAQ: SNY), NovoCure (NASDAQ: NVCR) and Geron (NASDAQ: GERN)

Tara BancroftTD Cowen

TD Cowen

Buy

210.08%

Upside

Reiterated

05/12/25

TD Cowen Sticks to Their Buy Rating for Geron (GERN)

Greg HarrisonScotiabank

Scotiabank

$4→$1.5

Hold

16.28%

Upside

Downgraded

05/08/25

Geron downgraded to Sector Perform from Outperform at ScotiabankGeron downgraded to Sector Perform from Outperform at Scotiabank

Robert DriscollWedbush

Wedbush

$7→$6

Buy

365.12%

Upside

Reiterated

05/08/25

Geron (GERN) Gets a Buy from Wedbush

Peter LawsonBarclays

Barclays

Buy

210.08%

Upside

Reiterated

05/08/25

Barclays Reaffirms Their Buy Rating on Geron (GERN)

Emily BodnarH.C. Wainwright

H.C. Wainwright

―

Hold

―

Reiterated

05/07/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Geron (NASDAQ: GERN) and Immunocore Holdings (NASDAQ: IMCR)

Gil BlumNeedham

Needham

Buy

287.60%

Upside

Reiterated

05/07/25

Positive Growth Prospects for Geron Amid Strategic Expansion and Strong Financial Position

Stephen WilleyStifel Nicolaus

Stifel Nicolaus

Buy

210.08%

Upside

Reiterated

03/12/25

Stifel Nicolaus Sticks to Its Buy Rating for Geron (GERN)

Kalpit PatelB.Riley Financial

B.Riley Financial

$3.5→$2

Hold

55.04%

Upside

Downgraded

02/26/25

Geron downgraded to Neutral from Buy at B. RileyGeron downgraded to Neutral from Buy at B. Riley

Carter GouldCantor Fitzgerald

Cantor Fitzgerald

Buy

597.67%

Upside

Assigned

11/08/24

Barclays Sticks to Its Buy Rating for Geron (GERN)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Geron

1 Month

xxx

Success Rate

6/12 ratings generated profit

Average Return

+8.43%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +8.43% per trade.

3 Months

xxx

Success Rate

13/26 ratings generated profit

Average Return

+4.21%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +4.21% per trade.

1 Year

Gil BlumNeedham

Success Rate

10/26 ratings generated profit

Average Return

+2.15%

reiterated a buy rating 2 months ago

Copying Gil Blum's trades and holding each position for 1 Year would result in 38.46% of your transactions generating a profit, with an average return of +2.15% per trade.

2 Years

xxx

Success Rate

8/26 ratings generated profit

Average Return

-8.64%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 30.77% of your transactions generating a profit, with an average return of -8.64% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GERN Analyst Recommendation Trends

Rating

Mar 25

Apr 25

May 25

Jun 25

Jul 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, GERN has received 6 Buy Ratings, 4 Hold Ratings, and 1 Sell Ratings. GERN average Analyst price target in the past 3 months is 3.58.

Each month's total comprises the sum of three months' worth of ratings.

GERN Financial Forecast

GERN Earnings Forecast

Next quarter’s earnings estimate for GERN is -$0.03 with a range of -$0.04 to -$0.01. The previous quarter’s EPS was -$0.03. GERN beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 38.43% of the time in the same period. In the last calendar year GERN has Preformed in-line its overall industry.

GERN Sales Forecast

Next quarter’s sales forecast for GERN is $48.03M with a range of $42.02M to $54.56M. The previous quarter’s sales results were $39.60M. GERN beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.77% of the time in the same period. In the last calendar year GERN has Preformed in-line its overall industry.

GERN Stock Forecast FAQ

What is GERN’s average 12-month price target, according to analysts?

Based on analyst ratings, Geron Corporation’s 12-month average price target is 3.58.

What is GERN’s upside potential, based on the analysts’ average price target?

Geron Corporation has 177.52% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is GERN a Buy, Sell or Hold?

Geron Corporation has a consensus rating of Moderate Buy which is based on 5 buy ratings, 2 hold ratings and 1 sell ratings.

What is Geron Corporation’s price target?

The average price target for Geron Corporation is 3.58. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $6.00 ,the lowest forecast is $1.00. The average price target represents 177.52% Increase from the current price of $1.29.

What do analysts say about Geron Corporation?

Geron Corporation’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 8 Wall Streets Analysts.

How can I buy shares of GERN?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Geron (GERN) Stock Forecast & Price Target

GERN Analyst Ratings

GERN Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Geron

GERN Analyst Recommendation Trends

GERN Financial Forecast

GERN Earnings Forecast

GERN Sales Forecast

GERN Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts